Objective To determine the validity of an electronic health record (EHR) in the identification of patients with left ventricular dysfunction in a primary care setting. Design A cross-sectional study. Setting Nine clinics participating from the Providence Research Network (PRN) comprising 75 physicians serving approximately 200 000 patients. All clinics utilise the Logician™ EHR for all patient care activities. Patients The study included all PRN patients with an active chart. Interventions All patients with a heart failure diagnosis in the problem list were identified by database query. Left ventricular ejection fraction (LVEF) data were identified through query of local cardiology and hospital echocardiography databases. Additional LVEF data were sought in a manual search of paper charts.
Introduction
A major focus of practice-based research networks (PBRN) is the translation of existing evidence into clinical practice. Through the rigorous evaluation of methods of translating research into practice in community settings, PBRNs have the potential to identify and assess implementation strategies that are most likely to be effective and sustainable. 1 Of
Refereed papers
A first step towards translating evidence into practice: heart failure in a community practice-based research network particular interest among PBRNs is the use of information technology, such as electronic health records (EHRs), in translating research findings into improvements in care.
Disease states that are optimal candidates for translational research are highly prevalent, associated with known effective therapies and suffer from undertreatment. Accordingly, the Providence Research Network (PRN) teamed researchers with practising physicians interested in improving care in the area of heart failure.
Strategies aimed at improving heart failure management begin with the accurate identification of candidate patients. Commonly, identification of patient populations with a specific condition (such as heart failure [HF]) can be accomplished by query of administrative or claims databases. The validity of such identification strategies can be determined using measures such as sensitivity, specificity and predictive values. This approach necessitates comparison of data with a 'gold standard' measurement. Sources of gold standard measurements include manual medical record abstraction, patient survey and electronic databases, alone or in combination. [2] [3] [4] [5] In one study, reliance on administrative data resulted in exclusion of approximately onethird of patients with clinical evidence of HF. 6 It has been suggested that EHRs represent a source of structured clinical data that complement or could even replace administrative data sources for the purpose of identifying patient populations and measuring quality of care. 7 Since the patient's diagnosis list is created and maintained in the EHR by their practitioner, it has the potential to be a very sensitive and specific identification source. Although several papers have described the validity of administrative data to identify patient populations, much less is known about the validity of EHR-derived data. 8, 9 Accordingly, the aim of this study was to determine the validity of EHR for identification of patients with systolic dysfunction using sensitivity, positive predictive value and related derived measures.
Methods

Study setting
The PRN is a community-based network of internal medicine and family practice clinics in Portland, Oregon. Network clinics participating in this study consisted of approximately 75 primary care providers caring for more than 200 000 patients in nine clinic locations. All practices share a common EHR, Logician™ (GE Medical Systems Information Technology, 20540 NW Evergreen Parkway, Hillsboro, OR 97124) that was implemented in most clinics by 1997. All office encounters and telephone contacts by all physicians and staff are documented in the EHR in a text-based format. The EHR problem lists are generated and maintained through physician entry of patient diagnosis, analogous to the traditional paper chart. Problem list entries are stored in a searchable format, based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) system. Additional patient data, including demographics, insurance status, medications and laboratory values, are available in a searchable database. Interfaces to the EHR allow providers to access laboratory and radiology results as well as hospital and emergency room records. During the study period external documents, such as records transferred from previous physicians, specialty consult letters and non-interfaced test results, were stored in a complementary paper chart.
The study population consists of all patients with an active record in the PRN's medical record database. Patients were excluded if they left a PRN clinic or died during the study period. Patients were defined as inactive and were also excluded if their electronic chart lacked documentation of any contact, including evidence of an office visit, telephone communication or prescription refill, between 1 January 1998 and 31 December 2000.
Methods
This study was a cross-sectional analysis comparing patient EHRs with independently maintained cardiology laboratory records. The study was approved by the local institutional review board in February 2001. Physician-entered diagnosis of HF in the EHR was reconciled against left ventricular ejection fraction (LVEF) as measured by echocardiography, angiography or nuclear imaging. These measurements of LVEF were used as the gold standard indicators for determining whether a patient had HF due to left ventricular dysfunction. Owing to ambiguity surrounding the definition of systolic dysfunction, two analyses were performed. Depressed left ventricular function was defined as an LVEF р55% for the first analysis and р40% for the second. The physician-entered diagnosis of HF was defined by the following search terms: ICD-9-CM 402. Table 1 ). At the time of this study, ICD-9-CM codes did not support differentiation among systolic dysfunction and other categories of HF. Accordingly, an inclusive list of HF codes was assembled.
The gold standard measure of LVEFs was constructed through several processes to ensure completeness. First, LVEF values were extracted from the echocardiography databases from all local laboratories utilised by PRN practitioners, including hospital and cardiology practice laboratories. It is unlikely that LVEF assessment would be performed outside of the local laboratories. Second, manual review was performed on all charts of patients identified with HF or an HF-related diagnosis in the problem list of the patient record. Any evidence of a test yielding a measured LVEF derived from an outside cardiology laboratory or any results mentioned in previous chart records or consult letters were extracted. Lastly, HF patients who were not identified in the previous steps were sought through a query of billing data and chart medication lists. The practice management software of PRN clinics was queried for evidence of billing for a service related to any of the referenced HF-related ICD-9-CM codes. Patients were also screened if carvedilol was present as an active or historical prescription in the chart medication list. Carvedilol was selected as an identifier because it is prescribed solely for HF. A chart review was then conducted to confirm or exclude the presence of a depressed LVEF. LVEF values from all of these sources were then aggregated to create the gold standard list of patients with confirmed systolic dysfunction. In the case of multiple LVEF values, the lowest value was selected for the purpose of the study.
Statistical analysis
The active population, stratified by presence or absence of a documented chart diagnosis of HF, was crossed with the gold standard list of patients with confirmed systolic dysfunction. A two-by-two table was used to calculate the following standard statistics applicable to diagnostic tests. The EHR problem list was treated as a diagnostic test for systolic dysfunction. A problem list entry for HF was considered a positive result for systolic dysfunction. Since determination of LVEF is a prerequisite for a diagnosis of systolic dysfunction, the absence of an LVEF entry was defined as a negative result.
The completeness and accuracy of the patient problem list were inferred by measures of sensitivity and positive predictive value, respectively. 5 The likelihood ratio for a positive result was the ratio of the chance of a positive result if the patient had the disease to the chance of a positive result if the disease was absent. In addition, we report the true positive to false negative ratio (TPFN), and the number of false negatives to total number of patients in the database ratio times 10 000 (DBFind 10 000 ), which are two newly developed and published statistical tools. 5 The DBFind 10 000 represents the number of false negatives in a database of 10 000 patients. The lower the TPFN ratio and the higher the DBFind 10 000 results, the greater the number of false negative cases in the database.
Results
Review of all sources of measured LVEF yielded 1403 patients in the PRN with an LVEF value р55%, of whom 793 had an LVEF р40%. The majority of LVEF values were identified from local echocardiography Table 2a ). Comparatively, when the LVEF definition is decreased to р40%, sensitivity increased to 54.4%, while positive predictive value fell to 24.9% (see Table 2b ). The likelihood ratio for a positive result increased modestly, to 85.7. Specificity of the EHR was 99.5% and 99.4% for an LVEF of р55% and р40% respectively, due largely to the low prevalence of HF.
TPFN, the ratio of true positives to false negatives, was 0.8 with an LVEF definition р55%, and increased to 1.2 when LVEF р40%. DBFind 10 000 decreased from 38.3 to 17.6 when the LVEF threshold was changed from р55% to р40%.
Discussion
Our analysis assessed the utility of a problem list entry for heart failure in an EHR to identify candidates for management of systolic dysfunction. Currently, accurate identification of individuals with systolic dysfunction for the purpose of providing targeted interventions is a difficult task. Structured medical data stored by an EHR may be expected to complement other data sources for a variety of uses, including quality improvement processes, disease management programmes and clinical research. Validation of the accuracy of EHR patient problem lists not only describes current physician practice, but is also a prerequisite in defining the broader utility of this information source. It has been suggested that the validity of these data is best characterised by statistical measures often applied to diagnostic tests, such as sensitivity, positive predictive value and likelihood ratios. 5 This study characterises the utility of a problem list database for identification of candidates for heart failure disease management interventions among 205 755 patients in a community-based primary care PBRN. Sensitivity and positive predictive value were dependent upon the LVEF value used to define systolic dysfunction, and are reported here for LVEF thresholds of 40% and 55%. In both cases sensitivity and positive predictive value are disappointing. The sensitivity of 54.4%, obtained even with the LVEF threshold set at 40%, implies that nearly half of the systolic dysfunction population would be overlooked using this search strategy. Likewise, the positive predictive value of 24.9%, determined at the same LVEF threshold, implies that a patient with a problem list entry for HF has only a one-quarter likelihood of documented systolic dysfunction.
The results of the derived statistics TPFN ratio and DBFind 10 000 also suggest poor validity of the problem list database. The latter statistic represents the number of false negatives in a database of 10 000 patients, and can therefore be used to quantify and compare the potential benefit of reconciliation of the database. Thus, with validation of the database one could expect to identify 17-38 additional patients with systolic dysfunction in every 10 000 patients.
These results are of increasing value based on the increasing prevalence of EHR use and the comparable processes for physician entry of diagnosis that exist across EHR types. However, the findings may not be reflective of data accuracy in countries such as the United Kingdom with a 99% prevalence of EHRs in primary care together with dedicated efforts to improve data quality and information management. 10, 11 The search capability of the EHR offers potential new uses for medical record data, including problem lists. One source of problem list inaccuracy may relate to This study has several limitations. The gold standard for defining a diagnosis of systolic dysfunction was a measured LVEF. As a result appropriately coded instances of diastolic dysfunction, in the presence of preserved or unmeasured systolic function, are deemed false positives. At the time of this analysis, HF diagnosis in the EHR problem list was incapable of distinguishing isolated diastolic dysfunction from systolic dysfunction, as there were no differentiating ICD-9-CM codes. The most recent revisions to the ICD-9-CM system now include codes specific for systolic (428.2x), diastolic (428.3x) and combined systolic and diastolic heart failure (428.4x). 12 Adoption of these newly revised codes in both clinical and administrative applications will benefit quality improvement, disease management and research initiatives. This study also was not designed to quantify occult systolic dysfunction, so problem list inaccuracy associated with undiagnosed heart failure remains undetermined. Finally, the criteria used to identify active patients are arbitrary, and this may have resulted in the inclusion of some patients no longer receiving care in PRN clinics.
Although the potential utility of accurate patient problem lists for such activities as disease management has been discussed, the implications of problem list inaccuracy in conventional practice remain undetermined. This may be elucidated through comparison of patterns of drug utilisation between patients in the true positive and false negative categories. It will be beneficial to determine whether false negative patients are less likely to receive valuable therapies, such as ACE inhibitors, beta blockers and spironolactone, or more likely to receive relatively contraindicated therapies, such as non-steroidal anti-inflammatory agents and dihydropyridine calcium channel antagonists.
Conclusion
In conclusion, the results of this validation study of EHR-stored patient problem list data in the primary care setting are disappointing. Assessment of accuracy is an important step in the evolving application of EHR data to patient care, disease management, clinical research and related activities. EHR database validity may be enhanced through integration with other clinical data sources. The ramifications of incomplete and inaccurate EHR databases are unknown and merit investigation.
